Obstetrics, gynecology, andrology, sexual and reproductive health

Tuberculosis

PubMed Free Full Text

Latent tuberculosis

 

Afghanistan

• PLoS ONE
  • Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study [2021]

Asia

• Respirology
  • Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: An Asian perspective [2013]

Australia

• Australian Journal of General Practice
  • Latent tuberculosis in the general practice context [2020]

• Department of Health Australia
  • Position statement on interferon-gamma release assays for the detection of latent tuberculosis infection [2018]
  • National position statement for the management of latent tuberculosis infection [2017]
  • Treatment of latent tuberculosis in migrants to Victoria [2015]
  • Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention [2015]

• Queensland Clinical Guidelines
  • Management of Latent Tuberculosis in Children up to 16 years
  • Management of Latent Tuberculosis in Adults

Australia, New Zealand

• Tuberculosis Research and Treatment
  • Management of Latent Tuberculosis Infections in Australia and New Zealand: A Review of Current Practice [2010]

Austria, Germany, Switzerland

• PLoS ONE
  • Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland [2021]

Brazil

• BMJ Global Health
  • Determinants of losses in the latent tuberculosis infection cascade of care in Brazil [2021]

Canada

• BMC Public Health
  • Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries [2018]

• BMJ Open
  • Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study [2017]

• Canadian Agency for Drugs and Technologies in Health
  • Interferon Gamma Release Assay for the Identification of Latent Tuberculosis Infection in Rural and Remote Settings [2021]
  • Latent Tuberculosis Infection Testing in People with Compromised Immunity Prior to Biologic Therapy: A Review of Diagnostic Accuracy, Clinical Utility, and Guidelines [2020]

• Public Health Agency of Canada
  • Latent tuberculosis infection: An overview [2017]
  • Canadian Tuberculosis Standards 7th Edition: 2014 – Treatment of Latent Tuberculosis infection [2014]
  • Canadian Tuberculosis Standards 7th Edition: 2014 – Diagnosis of Latent Tuberculosis infection [2014]
  • Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection - 2010 update [2010]

China

• International Journal of Infectious Diseases
  • Management of Latent Tuberculosis Infection in China: Exploring solutions suitable for high-burden countries [2020]

• Journal of Thoracic Disease
  • Risk of prevalence of latent tuberculosis infection in health care workers-an idiographic meta-analysis from a Chinese perspective [2021]

• PLoS ONE
  • Latent Tuberculosis Infection and Occupational Protection among Health Care Workers in Two Types of Public Hospitals in China [2014]

Colombia

• Multiple Sclerosis Journal - Experimental, Translational and Clinical
  • Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis [2018]

Europe

• European Centre for Disease Prevention and Control
  • Review of reviews and guidelines on target groups, diagnosis, treatment and programmatic issues for implementation of latent tuberculosis management [2018]
  • Programmatic management of latent tuberculosis infection in the European Union [2018]
  • Mathematical modelling of programmatic screening strategies for latent tuberculosis infection in countries with low tuberculosis incidence [2018]
  • Cost-effectiveness analysis of programmatic screening strategies for latent tuberculosis infection in the EU/EEA [2018]

• EuroSurveillance
  • Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA countries: A survey of national experts, September 2019 to February 2020 [2022]
  • The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review [2018]
  • Identifying components for programmatic latent tuberculosis infection control in the European Union [2016]

• TBNET
  • The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement [2012]
  • Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis [2011]
  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement [2010]
  • LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement [2009]

Germany

• International Journal of Environmental Research and Public Health
  • Latent Tuberculosis Infection among Health Workers in Germany—A Retrospective Study on Progression Risk and Use of Preventive Therapy [2021]

India

• BMJ Global Health
  • Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India [2018]

• Indian Journal of Medical Ethics
  • Ethical issues in expanding latent TB management in high burden countries [2020]

• Lung India
  • Management of latent tuberculosis infection: An evidence-based approach [2015]

International

• BMC Infectious Diseases
  • Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis [2021]

• BMC Public Health
  • Global trends and gaps in research related to latent tuberculosis infection [2020]

• BMJ Open
  • Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines [2018]

• European Respiratory Journal
  • Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries [2015]

• International Journal of Infectious Diseases
  • Preventive therapy for latent tuberculosis infection—the promise and the challenges [2017]

• International Journal of Tuberculosis and Lung Disease
  • TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up [2021]

• Lancet Infectious Diseases
  • Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis [2021]
  • Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling [2019]

• PLoS Medicine
  • The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling [2016]

Israel

• Israel Medical Association Journal
  • Interferon Gamma Release Assay-Guided Latent Tuberculosis Prophylaxis in Israel [2015]

Japan

• BMC Infectious Diseases
  • Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data [2021]

• Kekkaku (Tuberculosis)
  • Treatment guidelines for latent tuberculosis infection [2014]

• PLoS ONE
  • Trend and treatment status of latent tuberculosis infection patients in Japan – Analysis of Japan TB Surveillance data [2017]

Low and middle income countries

• Health Science Reports
  • How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers [2020]

• PLoS ONE
  • Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis [2016]

Middle East, North Africa

• Pulmonary Medicine
  • Prevalence of Latent Tuberculosis Infection in the Middle East and North Africa: A Systematic Review [2021]

Norway

• BMC Infectious Diseases
  • Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study [2018]

• BMJ Open
  • Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study [2019]

Republic of Korea

• Epidemiology and Health
  • An opposing view on including high school students in a latent tuberculosis infection control program in Korea [2017]

• Journal of Preventive Medicine and Public Health
  • Proposal to Revise the Screening Test for Latent Tuberculosis Infection in Close Contacts at Elementary Schools in Korea [2019]

• Tuberculosis and Respiratory Diseases
  • Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy [2018]
  • Diagnosis and Treatment of Latent Tuberculosis Infection in Healthcare Workers [2016]
  • Diagnosis and Treatment of Latent Tuberculosis Infection [2015]

Saudi Arabia

• Saudi Thoracic Society
  • Saudi guidelines for testing and treatment of latent tuberculosis infection [2010]

Singapore

• BMJ Open
  • Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore [2021]

• International Journal of Infectious Diseases
  • Prevalence of and risk factors associated with latent tuberculosis in Singapore: A cross-sectional survey [2018]

South-East Asia

• BMC Medicine
  • The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach [2020]

• WHO Regional Office for South-East Asia
  • A situational analysis of programmatic management of TB preventive treatment in the WHO South-East Asia Region [2020]

Spain

• Revista Española de Sanidad Penitenciaria
  • Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination [2021]

Sweden

• International Journal of Infectious Diseases
  • Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study [2021]

United Kingdom

• Public Health England
  • Latent tuberculosis testing and treatment programme for migrants
  • Latent TB infection (LTBI): testing and treatment

United States

• Agency for Healthcare Research and Quality
  • Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force [2023]

• American Journal of Nursing
  • Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States [2017]

• Centers for Disease Control and Prevention
  • Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 [2020]
  • Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection [2018]
  • Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011–2015 [2018]
  • Latent Tuberculosis Infection Resources

• Clinical Infectious Diseases
  • Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017 [2021]

• Medicine
  • A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States [2021]

• PLoS ONE
  • State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity [2021]

• U.S. Preventive Services Task Force
  • Latent Tuberculosis Infection in Adults: Screening [2023]

WHO

• World Health Organization
  • Report of the technical consultation on innovative clinical trial designs for evaluating new TB preventive treatments, virtual meeting, 15-17 September 2021 [2022]
  • WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment [2020]
  • WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment [2020]
  • Target product profiles for tuberculosis preventive treatment [2020]
  • Meeting of the Implementation Core Group of WHO Global Task Force on Latent TB Infection and country stakeholders on implementation tools and joint TB and HIV programming to scale up TB preventive treatment [2018]

{Related topics}

• Guidelines
  • Tuberculosis